OMCL logo

Omnicell (OMCL) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

09 August 2001

Indexes:

Not included

Description:

Omnicell, Inc. is a leading provider of automation solutions for medication management and adherence tools for healthcare systems and pharmacies. The current product portfolio includes: solutions for automating central pharmacies (XT Series automated dispensing systems for medications and supplies, automated storage and retrieval systems, compounder robots and workflow management systems; inventory management software), and solutions for hospitals, healthcare facilities (intravenous infusion control systems, medication and supply dispensing systems). The company was founded in 1992 under the name Omnicell Technologies, Inc. and reorganized in the state of Delaware in 2001 as Omnicell, Inc. The headquarters is located in Mountain View, California.

Events Calendar

Earnings

Next earnings date:

Feb 07, 2025

Recent quarterly earnings:

Oct 30, 2024

Recent annual earnings:

Feb 08, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

21 Nov '24 JP Morgan
Neutral
31 Oct '24 Craig-Hallum
Buy
31 Oct '24 Barclays
Equal-Weight
31 Oct '24 B of A Securities
Neutral
14 Oct '24 Wells Fargo
Equal-Weight
09 Oct '24 Benchmark
Buy
23 Aug '24 JP Morgan
Neutral
02 Aug '24 Wells Fargo
Equal-Weight
02 Aug '24 Barclays
Equal-Weight
02 Aug '24 B of A Securities
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference
OMCL
businesswire.com22 November 2024

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference.

Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering
Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering
Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering
OMCL
businesswire.com20 November 2024

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering.

Here's Why You Should Add OMCL Stock to Your Portfolio Now
Here's Why You Should Add OMCL Stock to Your Portfolio Now
Here's Why You Should Add OMCL Stock to Your Portfolio Now
OMCL
zacks.com18 November 2024

A robust Advanced Services portfolio and long-term growth initiatives bode well for Omnicell.

Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock
Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock
Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock
OMCL
zacks.com06 November 2024

Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised
OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised
OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised
OMCL
zacks.com31 October 2024

Omnicell continues its trend of impressive results in the third quarter of 2024.

Omnicell, Inc. (OMCL) Soars to 52-Week High, Time to Cash Out?
Omnicell, Inc. (OMCL) Soars to 52-Week High, Time to Cash Out?
Omnicell, Inc. (OMCL) Soars to 52-Week High, Time to Cash Out?
OMCL
zacks.com31 October 2024

Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Omnicell, Inc. (OMCL) Q3 2024 Earnings Call Transcript
Omnicell, Inc. (OMCL) Q3 2024 Earnings Call Transcript
Omnicell, Inc. (OMCL) Q3 2024 Earnings Call Transcript
OMCL
seekingalpha.com30 October 2024

Omnicell, Inc. (NASDAQ:OMCL ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Kathleen Neiman - Senior Vice President, Investor Relations Randall Lipps - Founder, Chairman, President & Chief Executive Officer Nchacha Etta - Executive Vice President & Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Jessica Tassan - Piper Sandler Allen Lutz - Bank of America Stephanie Davis - Barclays Anne Samuel - JPMorgan Scott Schoenhaus - KeyBanc Capital Markets Bill Sutherland - The Benchmark Company Stan Berenshteyn - Wells Fargo David Larsen - BTIG Operator Thank you for standing by. My name is John, and I'll be your conference operator today.

Omnicell Announces Third Quarter 2024 Results
Omnicell Announces Third Quarter 2024 Results
Omnicell Announces Third Quarter 2024 Results
OMCL
businesswire.com30 October 2024

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Third Quarter 2024 Results.

Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell
OMCL
zacks.com29 October 2024

Medical Systems, 10x Genomics and Omnicell have been highlighted in this Industry Outlook article.

Omnicell: Innovating Medication Management and Driving Growth in the Healthcare Sector
Omnicell: Innovating Medication Management and Driving Growth in the Healthcare Sector
Omnicell: Innovating Medication Management and Driving Growth in the Healthcare Sector
OMCL
etftrends.com11 October 2024

In this ROBO Global Robotics and Automation Index spotlight, we focus on Omnicell Inc (OMCL). The index underlies the $1.13 billion ROBO Global Robotics and Automation ETF (ROBO).

FAQ

  • What is the primary business of Omnicell?
  • What is the ticker symbol for Omnicell?
  • Does Omnicell pay dividends?
  • What sector is Omnicell in?
  • What industry is Omnicell in?
  • What country is Omnicell based in?
  • When did Omnicell go public?
  • Is Omnicell in the S&P 500?
  • Is Omnicell in the NASDAQ 100?
  • Is Omnicell in the Dow Jones?
  • When was Omnicell's last earnings report?
  • When does Omnicell report earnings?
  • Should I buy Omnicell stock now?

What is the primary business of Omnicell?

Omnicell, Inc. is a leading provider of automation solutions for medication management and adherence tools for healthcare systems and pharmacies. The current product portfolio includes: solutions for automating central pharmacies (XT Series automated dispensing systems for medications and supplies, automated storage and retrieval systems, compounder robots and workflow management systems; inventory management software), and solutions for hospitals, healthcare facilities (intravenous infusion control systems, medication and supply dispensing systems). The company was founded in 1992 under the name Omnicell Technologies, Inc. and reorganized in the state of Delaware in 2001 as Omnicell, Inc. The headquarters is located in Mountain View, California.

What is the ticker symbol for Omnicell?

The ticker symbol for Omnicell is NASDAQ:OMCL

Does Omnicell pay dividends?

No, Omnicell does not pay dividends

What sector is Omnicell in?

Omnicell is in the Healthcare sector

What industry is Omnicell in?

Omnicell is in the Health Information Services industry

What country is Omnicell based in?

Omnicell is headquartered in United States

When did Omnicell go public?

Omnicell's initial public offering (IPO) was on 09 August 2001

Is Omnicell in the S&P 500?

No, Omnicell is not included in the S&P 500 index

Is Omnicell in the NASDAQ 100?

No, Omnicell is not included in the NASDAQ 100 index

Is Omnicell in the Dow Jones?

No, Omnicell is not included in the Dow Jones index

When was Omnicell's last earnings report?

Omnicell's most recent earnings report was on 30 October 2024

When does Omnicell report earnings?

The next expected earnings date for Omnicell is 7 February 2025

Should I buy Omnicell stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions